SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AgomAb Therapeutics Form 4P: CFO buy of 10,000 shares

Form 4P shows CFO Kemula Pierre Thadee VictorP bought 10,000 shares at $8.594 each for $85,940.